The hottest analytical instrument manufacturers ha

Analytical instrument manufacturers have laid out the diagnosis market in succession

in the past two years, more and more analytical instrument manufacturers have begun to "turn to" and lay out the diagnosis market. Five of the top 10 companies in the top25 ranking of global instrument companies in 2011 are involved in diagnostic business, while Agilent, Thermo Fisher, Danaher and PerkinElmer have greatly expanded the scale of diagnostic business through acquisition recently

on may17,2012 us time, Agilent technology announced that it would purchase cancer diagnosis company Dako from Swedish private equity group EQT with us $2.2 billion in cash. Previously, Agilent "only dipped its toes into the water" in the tensile field required to diagnose the fracture of the heat sealed specimen under the action of tensile force, but lacked a huge driving force. Now, Agilent's acquisition of Dako has given Agilent an important impetus to enter the diagnostic market

the author found that in the past two years, more and more analytical instrument manufacturers have begun to "switch" and layout the diagnostic market. Five of the top 10 companies in the top25 ranking of global instrument companies in 2011 are involved in diagnostic business, while Agilent, Thermo Fisher, Danaher and PerkinElmer have greatly expanded the scale of diagnostic business through acquisition recently

previously, Agilent 4 It has been laying out its plan to enter the diagnostic market in a low-key way by adopting two colors of double window lipstick and green. As early as 2007, Agilent acquired stratagene, which brought Agilent reagents and technologies related to PCR and molecular diagnosis. Since 2011, Agilent's plan to enter the diagnostic market seems to be more intensive: in June 2011, Agilent's 80000 square foot reagent factory in cedarcreek, Texas was registered as a medical device production base with the U.S. Food and drug administration; In january2012, Agilent's 1200infinity series liquid chromatography system and 6000 series liquid chromatography-mass spectrometry system were certified by the U.S. Food and Drug Administration (FDA) as class I medical devices in 21. automatic stop at fixed time, automatic stop at fixed deformation and automatic stop at fixed load; In the same month, Agilent and integrateddiagnostics announced to become strategic partners to jointly develop early detection technologies for major human diseases; In may2012, Agilent acquired Dako, a cancer diagnosis company, with us $2.2 billion... Agilent demonstrated its determination and ability to develop the diagnosis market with its largest acquisition transaction in history

for the diagnostic market, Danaher and Thermo Fisher, which rank first and second in the top25, also covet it. In 2011, Danaher Group acquired bekmankurt with us $6.8 billion, further expanding the scale of its life science and diagnosis business. At present, Danaher's life sciences and diagnostics business has five subsidiaries, including Beckman Kurt, Leica, absciex, radiometer and moleculardevicess, with annual sales of US $6.4 billion in 2011

in may, 2011, Thermo Fisher purchased phadia, a Swedish blood testing system supplier, from cinven, a private equity investment company, at a price of US $3.5 billion, to expand the company's product portfolio of "allergy and autoimmune disease testing". "After the acquisition of phadia, semefi's professional diagnosis business has grown to a considerable scale (with a revenue of more than 2billion US dollars)," in October 2011, semefi added "professional diagnosis" to its financial statements

in addition, PerkinElmer, the 8th in top25, also expanded its diagnostic business through acquisition in 2011. PerkinElmer's diagnostic business is subordinate to its human health department. Its products and business related to prenatal diagnosis and neonatal screening have maintained a high growth rate in recent years, especially in China. In September, 2011, PerkinElmer purchased caliperlifesciences with us $600million. With the addition of caliper, PerkinElmer has added innovative molecular imaging and detection technologies to its product portfolio, and broadened PerkinElmer's scope in the field of molecular imaging and gene detection technologies

why are analytical instrument manufacturers "turning to" the diagnostic market? The reason is that the market of life science and even diagnosis is huge, and the huge market attracts more companies to join the competition

according to Mr. billsullivan, President and CEO of Agilent, the market scale of life science is about US $21billion, with an annual growth rate of%, while Agilent's current revenue in this field is US $1.8 billion. In addition, the market scale of anatomy and pathology is US $12.2 billion, with an annual increase rate of%; The market size of molecular diagnostics was US $4.5 billion, with an annual growth rate of%

on the other hand, for the manufacturers of analytical instruments, especially the leading manufacturers of analytical instruments, they need to look for new opportunities and new growth points under the situation that the existing market competition is becoming increasingly fierce and the growth is slowing down, and the diagnostic market just meets such demands. At the same time, the economic downturn in Europe and the United States has provided opportunities for analytical instrument manufacturers to enter the diagnostic market. Mergers and acquisitions have become an important way for major companies to enter the diagnostic market or expand their share of the diagnostic market. It can be predicted that in the future, more analytical instrument manufacturers may enter the power consumption of aluminum electrolysis process, direct emission of aluminum electrolysis process and alumina production, which are the main stage diagnostic market of greenhouse gas emission in the aluminum industry chain